#Endovascular arterial atherectomy
Link
Digital subtraction angiogram
Angioplasty/ stenting
Thrombolysis / mechanical thrombectomy for acute vascular thrombosis
Endovascular arterial atherectomy
Endovascular treatment of arterial aneurysm
Endovascular treatment of pseudo aneurysms
Embolisation for vascular malformations.
Endovascular aortic aneurysm repair (EVAR / ESVG)
Haemodialysis access interventions
Inferior Vena Cava filter insertion/retrieval
Endovenous laser/ RFA/ glue ablation for varicose veins
Percutaneous sclerotherapy of spider/ reticular/ perforator veins
Venous access
#Digital subtraction angiogram#Angioplasty/ stenting#Thrombolysis / mechanical thrombectomy for acute vascular thrombosis#Endovascular arterial atherectomy#Endovascular treatment of arterial aneurysm#Endovascular treatment of pseudo aneurysms#Embolisation for vascular malformations.#Endovascular aortic aneurysm repair (EVAR / ESVG)#Haemodialysis access interventions#Inferior Vena Cava filter insertion/retrieval#Endovenous laser/ RFA/ glue ablation for varicose veins#Percutaneous sclerotherapy of spider/ reticular/ perforator veins#nous access
0 notes
Text
Latest Innovations in Artery Replacement Procedures
Artery replacement procedures have undergone remarkable advancements in recent years, revolutionizing the treatment landscape for cardiovascular diseases. From minimally invasive techniques to groundbreaking technologies, the field continues to evolve rapidly, offering patients safer and more effective treatment options than ever before. In this blog, we'll delve into the latest innovations shaping artery replacement procedures and their impact on patient care and outcomes.
Understanding Minimally Invasive Approaches:
One of the most significant developments in artery replacement procedures is the rise of minimally invasive techniques. Traditional open-heart surgeries are being replaced by less invasive procedures such as endovascular surgery and percutaneous interventions. These approaches involve smaller incisions, shorter recovery times, and reduced risks compared to conventional surgery.
Endovascular Surgery: A Game-Changer in Artery Replacement:
Endovascular surgery involves accessing the affected artery through small incisions and using specialized instruments to repair or replace the damaged vessel. Techniques like angioplasty and stenting have become standard procedures for treating arterial blockages. The use of advanced imaging technologies, such as fluoroscopy and intravascular ultrasound, allows for precise placement of stents and optimal outcomes.
Percutaneous Interventions: Enhancing Precision and Safety:
Percutaneous interventions, including balloon angioplasty and atherectomy, offer minimally invasive alternatives to traditional artery replacement surgery. These procedures utilize catheters and small instruments inserted through the skin to clear blockages and restore blood flow. With advancements in device technology and techniques, percutaneous interventions have become safer and more effective in treating complex arterial disease.
Innovative Technologies Driving Progress:
The integration of innovative technologies is propelling the field of artery replacement forward, enabling physicians to achieve better outcomes with fewer complications. Robotics-assisted surgery, for example, allows for greater precision and control during procedures, reducing the risk of errors and optimizing patient recovery. Additionally, advancements in bioresorbable scaffolds and tissue engineering hold promise for creating more durable and biocompatible artery replacements.
Personalized Medicine in Artery Replacement:
Another notable innovation in artery replacement procedures is the shift towards personalized medicine. By tailoring treatment plans to individual patient characteristics and genetic profiles, physicians can optimize outcomes and minimize risks. Advancements in imaging techniques, such as CT angiography and 3D modeling, enable clinicians to assess arterial anatomy with unprecedented accuracy, guiding treatment decisions and improving patient selection for artery replacement procedures.
The latest innovations in artery replacement procedures represent a paradigm shift in cardiovascular care, offering patients safer, more effective, and personalized treatment options. As technology continues to advance, the future holds immense promise for further improving outcomes and enhancing the quality of life for individuals with arterial disease. At PatientSelfTesting, we are committed to staying at the forefront of these developments, empowering patients and healthcare providers with innovative solutions for artery replacement procedures.
0 notes
Text
PERIPHERAL VASCULAR DISEASE- PVD Treatment in Mumbai
Dr. Kunal Arora is a seasoned Vascular and Interventional Radiologist based in Mumbai at the Endovascular Care Center. With a wealth of experience exceeding 5 years, he excels in non-surgical, minimally invasive treatments for a range of conditions. Dr. Arora's focus areas encompass varicose veins, DVT, peripheral arterial disease, embolization, oncologic intervention, hepatobiliary interventions, and dialysis AV fistula salvage.
Peripheral Vascular Disease (PVD) is a condition characterized by circulation issues in blood vessels outside the heart, predominantly affecting the legs and feet. Here is a concise and informative blog on PVD treatment in Mumbai:
Understanding Peripheral Vascular Disease
Peripheral Vascular Disease (PVD) involves the narrowing, blockage, or spasms in blood vessels, impacting blood flow to organs. Commonly affecting arteries due to atherosclerosis, PVD can lead to symptoms like leg pain during exercise and non-healing wounds.
Causes and Symptoms
Causes of PVD include plaque buildup, inflammation, injuries, and radiation exposure. Symptoms range from leg pain to ulcers, numbness, and skin changes. Risk factors include smoking, diabetes, high blood pressure, and family history of heart disease.
Diagnosis and Stages
Diagnosis involves medical history, physical exams, and tests like ABI, Doppler ultrasound, MRA, CTA, and angiography. Stages range from asymptomatic to ulcers or gangrene based on severity.
Peripheral Vascular Disease (PVD) progresses through different stages, each indicating the severity of the condition and guiding treatment decisions. Here is a detailed overview of the stages of Peripheral Vascular Disease:
Stage I: Asymptomatic -At this stage, individuals with PVD may not exhibit any noticeable symptoms.
Stage IIa: Mild Claudication -Patients experience mild leg pain during exercise, known as intermittent claudication.
Stage IIb: Moderate to Severe Claudication -Progressing from mild claudication, individuals may experience more pronounced leg pain during physical activity.
Stage III: Ischemic Rest Pain -At this stage, patients may experience pain in their legs even at rest.
Stage IV: Ulcers or Gangrene -The most severe stage of PVD is characterized by the development of ulcers or gangrene.
Understanding these stages is essential for healthcare providers to tailor treatment plans effectively based on the severity of the disease. Early detection and appropriate management can significantly improve outcomes for individuals with Peripheral Vascular Disease.
Treatment Options
Treatment aims to manage symptoms and improve artery health. Lifestyle changes like quitting smoking and medication for blood thinning are common. In severe cases, revascularization through endovascular or surgical procedures may be necessary.
Endovascular Treatments
Interventional radiologists perform minimally invasive procedures like angioplasty, stenting, atherectomy, and thrombolysis to restore blood flow in blocked arteries. These procedures offer benefits such as quicker recovery times and lower risk of complications compared to traditional surgery.
Prevention Strategies
Preventing PVD involves lifestyle changes like quitting smoking, regular exercise, healthy diet, managing blood pressure and cholesterol levels, controlling diabetes, maintaining a healthy weight, limiting alcohol intake, taking prescribed medications, and attending regular check-ups for early detection.
By understanding the causes, symptoms, diagnosis methods, treatment options, and prevention strategies for PVD in Mumbai, individuals can take proactive steps towards managing this condition effectively.
For those seeking consultation or wishing to schedule an appointment with Dr. Kunal Arora, the process is simple. Patients can reach out to his private clinic located in SRV Hospital, Goregaon, Mumbai. Additionally, appointments can be scheduled by contacting +91 90040 93090, ensuring accessibility for individuals in need of his expertise.
Click here to know more.
#vascularhealth#endovascular care centre#interventional radiologist in mumbai#best varicose treatment#veintreatment#deep vein thrombosis#best interventional radiologist in mumbai#varicoseveintreatment#dr. kunal arora#healthcare
0 notes
Text
Peripheral Vascular Devices Market Worth $12.02 Billion by 2028
Meticulous Research – a leading global market research company published a research report titled “Peripheral Vascular Devices Market by Type [Angioplasty Balloon, Stents, Catheters (Guiding, IVUS), IVC Filter, Atherectomy, Thrombectomy, Hemodynamic Flow Alteration (Embolic Protection, Occlusion)] and Geography - Global Forecast to 2028”.
According to this latest publication from Meticulous Research, the global peripheral vascular devices market is expected to grow at a CAGR of 6.9% from 2021 to reach $12.02 billion by 2028. The increasing prevalence of peripheral vascular diseases, rising incidence of diabetes, and rising demand for minimally invasive treatment procedures majorly drive the peripheral vascular devices market. Additionally, emerging economies is one of the factors expected to offer significant growth opportunities for the players operating in this market. However, product failures and recalls is expected to hinder the growth of this market.
Peripheral Vascular Devices Market: Future Outlook
The global peripheral vascular devices market study presents historical market data in terms of values (2019 and 2020), estimated current data (2021), and forecasts for 2028 by type [angioplasty balloons (old/normal balloons, drug-eluting balloons, cutting & scoring balloons); angioplasty stents (drug-eluting stents, bare-metal stents (balloon-expandable stents, self-expandable stents)); catheters (angiography catheters, guiding catheters, IVUS/OCT catheters); endovascular aneurysm repair stent grafts (abdominal aortic aneurysm stent-grafts, thoracic aortic aneurysm stent grafts); inferior vena cava filters (retrievable filters, permanent filters); plaque modification devices (atherectomy devices, thrombectomy devices); hemodynamic flow alteration devices (embolic protection devices, chronic total occlusion devices); and other devices] and geography. The study also evaluates industry competitors and analyses the market at the regional and country level.
Based on type, the peripheral vascular devices market is segmented into angioplasty stents, angioplasty balloons, catheters, endovascular aneurysm repair stent grafts, inferior vena cava filters, plaque modification devices, hemodynamic flow alteration devices, and other types. In 2021, the angioplasty stents segment is estimated to account for the largest share of the peripheral vascular devices market. Factors driving the growth of this segment include reduced restenosis rate associated with these products and their benefits, such as smaller incisions, faster recovery time, and lower risk of complications.
Based on geography, this research report analyzes and provides comprehensive analysis for North America (U.S. and Canada), Europe (Germany, France, U.K., Italy, Spain, and Rest of Europe), Asia-Pacific (Japan, China, India, and RoAPAC), Latin America, and the Middle East & Africa. In 2021, North America is estimated to dominate the peripheral vascular devices market, followed by Europe and Asia-Pacific. Factors such as the increasing prevalence of peripheral artery diseases, aortic aneurysms, and pulmonary embolisms; increasing number of obese & diabetic population; and the presence of key players are driving the growth of this regional segment.
The key players operating in the peripheral vascular devices market are Abbott Laboratories (U.S.), B. Braun Melsungen AG (Germany), Becton, Dickinson and Company (U.S.), BIOTRONIK SE & Co. KG (Germany), Blue Sail Medical Co., Ltd. (China), Boston Scientific Corporation (U.S.), Cardinal Health, Inc. (U.S.), Cook Group (U.S.), Edwards Lifesciences Corporation (U.S.), iVascular (Spain), Koninklijke Philips N.V. (Netherlands), Medtronic Public Limited Company (Ireland), Nipro Corporation (Japan), TE Connectivity LTD. (Switzerland), and Terumo Corporation (Japan), among others.
Download Free Sample Copy : https://www.meticulousresearch.com/download-sample-report/cp_id=5180
Key questions answered in the report-
Which are the high growth market segments in terms of type and region/countries?
What was the historical market for peripheral vascular devices across the globe?
What are the market forecasts and estimates for the period 2021–2028?
What are the major drivers, restraints, opportunities, and challenges in the global peripheral vascular devices market?
Who are the major players in the peripheral vascular devices market?
How is the competitive landscape, and who are the market leaders in the global peripheral vascular devices market?
What are the recent developments in the global peripheral vascular devices market?
What are the different strategies adopted by the major players in the global peripheral vascular devices market?
What are the geographical trends and high growth regions/countries?
Contact Us:
Meticulous Research®
Email- [email protected]
Contact Sales- +1-646-781-8004
Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-research
0 notes
Text
Germany Peripheral Artery Disease Market Size Expected To Acquire USD 8.121 billion By 2030 At 8.80% Compound Annual Growth Rate
The latest market report published by Credence Research, Inc. “Global Peripheral Artery Disease Market: Growth, Future Prospects, and Competitive Analysis, 2016 – 2028. The worldwide peripheral artery disease market has grown steadily in recent years and is predicted to increase at an 8.80% CAGR between 2023 and 2030. In 2022, the market was valued at USD 3.9 billion, and it is predicted to reach USD 7.0 billion by 2030.
The market is expected to witness substantial growth due to several factors, including a growing geriatric population, improved insurance and reimbursement policies, and the demand for non-invasive treatment alternatives and technological advancements.
The report divides the global peripheral artery disease market into four segments: material, application, distribution channel, and geography. The oral segment has emerged as the most popular and in-demand segment, while the catheter segment is projected to experience significant growth. Hospitals and specialist clinics are the primary user groups, and retail pharmacy and hospital pharmacy hold a significant market share. North America dominates the market expansion, accounting for nearly 40% of the PAD market.
Key drivers of the global peripheral artery disease market include the increasing geriatric population and better insurance and reimbursement policies. However, the market faces challenges such as under diagnosis and a lack of awareness among patients and healthcare providers, as well as expensive treatment options. Despite these hurdles, the market offers substantial growth opportunities, driven by the rising demand for non-invasive treatment alternatives and technological advancements.
Moreover, awareness campaigns and educational initiatives have gained momentum to educate both physicians and patients about the importance of early intervention and lifestyle modifications to prevent disease progression. The emergence of minimally invasive endovascular techniques has revolutionized treatment options for PAD, offering less pain, shorter hospital stays, quicker recovery times, and lower complication rates compared to traditional surgical interventions.
Germany Peripheral Artery Disease Market opportunities are abundant and present a promising landscape for businesses operating in the healthcare sector. With an increasing prevalence of peripheral artery disease (PAD) among the German population, there is a growing demand for effective treatment options and innovative medical devices. This presents an opportunity for pharmaceutical companies to develop novel drugs that can effectively manage PAD symptoms and improve patients' quality of life. Additionally, the market offers scope for medical device manufacturers to introduce cutting-edge technologies such as stents, angioplasty balloons, and atherectomy devices that aid in restoring blood flow to blocked arteries. Moreover, advancements in minimally invasive procedures have opened doors for catheter-based interventions, further expanding treatment possibilities within the country.
Why to Buy This Report-
The report provides a qualitative as well as quantitative analysis of the global Peripheral Artery Disease Market by segments, current trends, drivers, restraints, opportunities, challenges, and market dynamics with the historical period from 2016-2020, the base year- 2021, and the projection period 2022-2028.
The report includes information on the competitive landscape, such as how the market's top competitors operate at the global, regional, and country levels.
Major nations in each region with their import/export statistics
The global Peripheral Artery Disease Market report also includes the analysis of the market at a global, regional, and country-level along with key market trends, major players analysis, market growth strategies, and key application areas.
Browse Full Report: https://www.credenceresearch.com/report/peripheral-artery-disease-market
Visit: https://www.credenceresearch.com/
Browse Our Blog: https://www.linkedin.com/pulse/germany-peripheral-artery-disease-market-size-worth-usd-singh
Browse Our Blog: https://tealfeed.com/china-peripheral-artery-disease-market-grow-psuhi
0 notes
Text
Global Endovascular Devices Market valued at US$ 5.4 bn in 2021 and is anticipated to grow at a CAGR of 5% By 2026
Endovascular surgery is an advanced procedure that is performed using minimally invasive catheter techniques on the arteries or veins. Procedures include aneurysm repair, cardiovascular disorders, peripheral vascular diseases, renal vascular diseases, deep vein thrombosis (DVT), varicose vein repair, stroke, among others. A wide variety of guidewires, catheters, crossing devices, balloons, stents, atherectomy devices, drug-coated devices, and other devices are used for endovascular treatment.
The Global Endovascular Devices Market valued at US$ 5.4 bn (2021) is projected to witness a growth rate of 5% in the next five years. Rising preference for endovascular aneurysm repair (EVAR) procedures, technological advancements in endovascular devices, the increasing geriatric population & corresponding rise in the prevalence of cardiovascular diseases, lifestyle factors (diet, exercise), ease & availability of endovascular procedures, and favorable reimbursements for endovascular procedures are some of the key factors driving the global Endovascular devices market.
Cumulative Preference for Endovascular Aneurysm Repair (EVAR) Procedure Opens Growth Opportunities for Endovascular Devices Market
An aortic aneurysm is a bulge that occurs in the wall of the aorta that carries blood from the heart to the body. It increases the risk of developing a tear in the inner layer of the wall of the aorta. An aortic aneurysm can be abdominal or thoracic. An abdominal aortic aneurysm (AAA) occurs when a portion of the abdominal aorta bulges into an aneurysm because of a weakening of the vessel wall. AAA may result in life-threatening internal bleeding upon rupture and hence patients diagnosed with AAA are treated with open surgical repair or mostly via less invasive endovascular aneurysm repair (EVAR). During the EVAR procedure, a stent graft is inserted into the aorta which protects the aorta from tearing.
The EVAR is widely accepted as a standard of care for aortic aneurysms & supported by vascular surgeons due to the following benefits:
Shorter stay in the hospital.
Relatively less blood loss
Faster return to routine activities
Shorter procedure time as compared to open surgery, among others
Citing the lucrative prospects of EVAR technology, companies are launching innovative products in new markets.
For instance,
In May 2021, Endologix launched Alto® Abdominal Stent Graft System in Canada and Argentina. The launch boots the company’s global reach with the latest endovascular aneurysm repair (EVAR) technology
“Endovascular aneurysm repair (EVAR) has emerged as a safe, and effective method of treating abdominal aortic aneurysms as it lowers the risk of life-threatening tears & ruptures. Technological advancements in EVAR have not only allowed vascular surgeons to achieve therapeutic aims but also reduced procedural risks and patient discomfort." - Director, Leading Endovascular Device Manufacturer, United States
Explore Premium Report on Endovascular Devices Market @ https://meditechinsights.com/endovascular-devices-market/
Technological Advancements Drive the Global Endovascular Devices Market
The endovascular devices market is a technology-driven market and is marked by product enhancements/innovations.
For instance,
In June 2022, Medtronic India launched a fourth-generation flow diverter, Pipeline Vantage with Shield Technology for endovascular treatment of brain aneurysms
Organic and Inorganic Advance Strategies Adopted by Players to Establish Their Position in Endovascular Devices Market
The endovascular devices market is marked by the presence of both established and new players. Players operating in the market adopt both organic and inorganic growth strategies such as acquisitions, and new product launches to garner market share.
For instance,
In March 2022, Cook Medical received FDA Breakthrough Device Designation for Zenith® Thoraco+ Endovascular System. The Thoraco+ is built on the strength of the proven Zenith platform and represents a next-generation endovascular graft for the treatment of thoracoabdominal aortic aneurysms. The system is indicated for the endovascular treatment of patients with thoracoabdominal aortic aneurysm
The endovascular devices market is expected to continue to grow in the coming years due to growing cases of peripheral, aortic, & venous diseases, an increase in the smoking population, growth opportunities in the APAC region, technological advancements in endovascular devices, and favorable reimbursement in key markets.
Competitive Landscape Analysis of Endovascular Devices Market
The global endovascular devices market is marked by the presence of players such as Cordis, Medtronic, Boston Scientific, Cook Medical, Abbott, Gore Medical, Cardiovascular Systems, Inc. (CSI), Terumo, among others.
For More Detailed Insights, Contact Us @ https://meditechinsights.com/contact-us/
About Medi-Tech Insights
Medi-Tech Insights is a healthcare-focused business research & insights firm. Our clients include Fortune 500 companies, blue-chip investors & hyper-growth start-ups. We have completed 100+ projects in Digital Health, Healthcare IT, Medical Technology, Medical Devices & Pharma Services.
Contact:
Ruta Halde
Associate, Medi-Tech Insights
+32 498 86 80 79
0 notes
Photo
The Outpatient Endovascular & Surgical Journal (OESJ) highlights the importance of the type of care taking place in the outpatient setting for a subset of patients with peripheral arterial disease (PAD), and it will underscore the surprising range of tools available for PAD therapists to treat their patients safely and effectively. OESJ will explore real-world clinical challenges and the treatment options that PAD therapists can use to improve clinical outcomes in the daily outpatient setting. The Jetstream and Rotarex Atherectomy devices use active aspiration, which makes it useful in treating plaque with thrombus, such as chronic total occlusions.
0 notes
Video
Atherectomy is an endovascular surgical technique that removes plaques from the Artery. The Jetstream device does this by rotating and aspirating.
Learn More About cardiology: https://drboonlim.co.uk/
1 note
·
View note
Text
Endovascular Therapy Devices Market is expected to register a healthy CAGR during the forecast period.
Endovascular therapy Devices: Market Insights
A procedure involving endovascular therapy devices are used to insert a flexible, sterile plastic tube, stents or a catheter into a blood vessel to allow blood to be withdrawn from or medication to be delivered to a patient’s bloodstream over a period of time. These endovascular therapy devices can be used either for intravenous antibiotic treatment, chemotherapy, long-term intravenous feeding and blood transfusions. The market is challenged by many medical complexities requiring cardiovascular disease treatment from inside the blood vessel, strokes and other cardiovascular conditions. The market of endovascular therapy devices contains products which are less invasive, requiring patients to spend less time in the hospital, less recovery time and devices which cause less pain. The endovascular therapy devices market is dominated by minimally invasive, catheter-based procedure. These procedures are often performed in a cardiac catheterization labs present in hospitals.
Endovascular therapy Devices: Market Dynamics
The global endovascular therapy devices market will increase in forecast period 2018-28. Endovascular therapy devices market will be driven primarily by the rise in incidence of cardiovascular patients, economic power in some regions leading to lifestyle change, growing disposable income and, increasing expenditure. In addition, recent developments in stent technology and increased experience of interventionists will propel the growth of the global endovascular therapy devices market in the future. However, high cost involved in usage of new endovascular therapy devices, less awareness in economically poor nations, and US’s stringent tax regulation rules on medical devices are expected to be some of the major restraints in global market for endovascular therapy devices market.
Request Sample Report @https://www.futuremarketinsights.com/reports/sample/rep-gb-7693
Endovascular therapy Devices Market: Segmentation
Segmentation by Product Type:
Percutaneous endovascular aneurysm repair (EVAR)
Fenestrated EVAR
Aortic stents
Biodegradable Stents
Self-expanding Nitinol Stents
Thoracic aortic aneurysms grafts
Other Devices
Segmentation by Procedures:
Balloon Angioplasty
Angioplasty with Stent Placement
Drug-Eluting Stents (DES)
Renal Artery Angioplasty and Stenting
Carotid Artery Stenting
Transfemoral Carotid Artery Stenting
Transcarotid Artery Revascularization
Intravascular Brachytherapy
Atherectomy
Thrombolysis
Segmentation by Application
Pulmonary
Vascular
Cardiology
Surgery
Neurology
Radiology
Segmentation by End User Type:
Hospitals
Clinics
Research Institutes
Endovascular therapy Devices Market: Overview
The endovascular therapy devices market has grown exponentially since its inception in the early 1990s. Global estimates for the market reflects several factors. The use of manual compression has significantly lowered down in obese patients or patients on anticoagulation. However, complex procedures performed with a percutaneous endovascular therapy devices have taken strides as they offer bigger sheath sizes. As the economic landscape of health care becomes more competitive, endovascular therapy devices are becoming increasingly valuable because it frees up time for other work. Current market trends are focused on developing endovascular therapy devices that can be safe and efficient enough to close large-caliber femoral arteriotomies. As transcatheter aortic valve repair and percutaneous endovascular aneurysm repair are increasing in popularity, there will be tremendous opportunity for the manufacturers in the market to develop and manufacture simple but effective endovascular therapy devices in future..
Endovascular therapy Devices Market: Region-wise Outlook
Globally, global Endovascular therapy Devices market is segmented into seven key regions viz. North America, Latin America, Western Europe, Eastern Europe, Asia Pacific excluding Japan, Japan, and Middle East. North America will account for the largest share in global Endovascular therapy Devices market. Besides the region’s Endovascular therapy Devices market growth will also increase due to obesity and diet, and new products lunch due to presence of leading manufacturers in the region. Europe with robust healthcare infrastructure, will drive the endovascular therapy devices market in this region. Technological advances in the region in the past decade have shifted revascularization strategies from traditional open surgical approaches. Focus has shifted towards lower-morbidity percutaneous endovascular treatments for patients with peripheral arterial disease. Asia Pacific mainly including India, China, AUS&NZ and Latin American countries are expected to be a significant market contributors in the rising Endovascular therapy Devices market. Advancements in stent designs by leading and local manufacturers in the region have fueled the growth of endovascular therapy devices in the region due liberalization of healthcare polices and trade related implications.
Request to View TOC @ https://www.futuremarketinsights.com/toc/rep-gb-7693
Endovascular therapy Devices Market: Key Players
Some of the key players present in global Endovascular therapy Devices market include Cardinal Health, Altura Medical, Lifetech Scientific BiFlow Medical, Boston Scientific, Endospan, Getinge, InspireMD, Japan Lifeline, Lombard Medical Technologies, Endologix, Medtronic, Nellix, Penumbra and Terumo. In addition presence of small and local manufacturers across the countries will account for competiveness in Endovascular therapy Devices market.
1 note
·
View note
Text
Peripheral Vascular Devices Market to be Worth $11.13 Billion by 2027- Exclusive Report Covering Pre and Post COVID-19 Market Analysis and Forecasts by Meticulous Research®
According to a new market research report “Peripheral Vascular Devices Market by Type [Angioplasty Balloon, Stents, Catheters (Guiding, IVUS), IVC Filter, Atherectomy, Thrombectomy, Hemodynamic Flow Alteration (Embolic Protection, Occlusion)] and Geography - Global Forecast to 2027”, published by Meticulous Research®, the peripheral vascular devices market is expected to grow at a CAGR of 6.2% from 2020 to reach $11.13 billion by 2027.
Download Free Sample Report Now @ https://www.meticulousresearch.com/download-sample-report/cp_id=5180
Peripheral vascular diseases cause blockage or narrowing of blood vessels in the neck, arms, legs, or abdomen, except in the heart and brain vessels. This blockage or reduced blood supply in peripheral vessels increases the risk for heart attacks or strokes and, when left untreated, can lead to amputations. Several surgeries are used to treat peripheral vascular diseases, such as balloon angioplasty and stenting, ablation, artery bypass, embolization, and vena cava filter placement, among others. These treatment procedures are carried out using peripheral vascular devices, such as angioplasty balloons, angioplasty stents, catheters, EVAR stent grafts, inferior vena cava filters, atherectomy devices, thrombectomy devices, embolic protection devices, chronic total occlusion devices, and other devices.
The increasing prevalence of peripheral vascular diseases associated with obesity, diabetes, and hypertension; growing geriatric population; increasing demand for minimally invasive treatment options; and increasing prevalence of disease-causing lifestyles are the major factors driving the growth of this market.
Have Any Query? Speak to Analyst at https://www.meticulousresearch.com/speak-to-analyst/cp_id=5180
Impact of COVID-19 on the Peripheral Vascular Devices Market
On March 11, 2020, the WHO declared COVID-19 a pandemic and instructed nations to take immediate action to prevent and minimize transmission. Lockdowns and restrictions were implemented in countries all over the world. As a result, normal healthcare services were shifted to emergency-only services. Elective and non-emergency surgeries were thus postponed in hospitals and clinics. During the peak of the pandemic, an estimated 28 million activities were canceled or postponed.
The impact of the first wave of COVID-19 presented as a substantial challenge for Germany's surgical care system. Significant delays in the urgent and semi-elective surgical procedures may have been observed due to a reduction in bed and operating room capacity.
According to a study published in the Heart Journal, substantial reductions in the activities were observed in the U.K., with reductions in carotid endarterectomy, peripheral arterial procedures, and aortic aneurysm repairs.
According to the Journal of Vascular Surgery, the supply chain posed issues for devices such as thrombectomy catheters and peripheral vascular grafts in Italy. According to an article in Vascular News, there was an 80% reduction in beds and 84% reduction of operating rooms for elective surgeries in the first week of the pandemic outbreak, while 43% of the hospitals were not conducting any elective surgeries in Italy.
Moreover, due to global lockdowns, there was also a disruption in the supply chain and a slowdown in production. This resulted in delays in medical device procurement and surgical resource availability. As a result, the COVID-19 pandemic poses a challenge to the peripheral vascular devices market, which may temporarily hinder the market growth.
The peripheral vascular devices market is mainly segmented by type [angioplasty balloons (old/normal balloons, drug-eluting balloons, cutting & scoring balloons); angioplasty stents (drug-eluting stents, bare-metal stents (balloon-expandable stents, self-expandable stents)); catheters (angiography catheters, guiding catheters, IVUS/OCT catheters); endovascular aneurysm repair stent grafts (abdominal aortic aneurysm stent-grafts, thoracic aortic aneurysm stent grafts); inferior vena cava filters (retrievable filters, permanent filters); plaque modification devices (atherectomy devices, thrombectomy devices); hemodynamic flow alteration devices (embolic protection devices, chronic total occlusion devices); and other devices]; and geography. The study also evaluates industry competitors and analyses the market at the regional and country level.
Based on type, the peripheral vascular devices market is segmented into angioplasty stents, angioplasty balloons, catheters, endovascular aneurysm repair stent grafts, inferior vena cava filters, plaque modification devices, hemodynamic flow alteration devices, and other types. In 2020, the angioplasty stents segment accounted for the largest share of the overall peripheral vascular devices market. Factors driving the growth of this segment include reduced restenosis rate associated with these products and their benefits, such as smaller incisions, faster recovery time, and lower risk of complications.
Buy now and get upto 20% discount on this report @ https://www.meticulousresearch.com/Checkout/68638815
Based on geography, this research report analyzes and provides comprehensive analysis for North America (U.S. and Canada), Europe (Germany, France, U.K., Italy, Spain, and Rest of Europe), Asia-Pacific (Japan, China, India, and RoAPAC), Latin America, and the Middle East & Africa. In 2020, North America dominated the global peripheral vascular devices market, followed by Europe and Asia-Pacific. Factors such as the increasing prevalence of peripheral artery diseases, aortic aneurysms, and pulmonary embolisms; increasing number of obese & diabetic population; and the presence of key players are driving the growth of this regional segment.
The report also includes an extensive assessment of the product portfolio, geographic analysis, and key strategic developments adopted by leading market participants in the industry over the past four years. The peripheral vascular devices market has witnessed numerous new product launches, approvals & clearance, agreement, collaboration, and partnerships, and acquisitions in recent years.
The key players operatig in the global peripheral vascular devices market are Abbott Laboratories (U.S.), B. Braun Melsungen AG (Germany), Becton, Dickinson and Company (U.S.), BIOTRONIK SE & Co. KG (Germany), Blue Sail Medical Co., Ltd. (China), Boston Scientific Corporation (U.S.), Cardinal Health, Inc. (U.S.), Cook Group (U.S.), Edwards Lifesciences Corporation (U.S.), iVascular S.L.U. (Spain), Koninklijke Philips N.V. (Netherlands), Medtronic Public Limited Company (Ireland), Nipro Corporation (Japan), TE Connectivity LTD. (Switzerland), and Terumo Corporation (Japan), among others.
To gain more insights into the market with a detailed table of content and figures, click here: https://www.meticulousresearch.com/product/peripheral-vascular-devices-market-5180
Scope of the Report:
Peripheral Vascular Devices Market, by Type
Angioplasty Balloons
Angioplasty Stents
Catheters
Endovascular Aneurysm Repair Stent Grafts
Inferior Vena Cava Filters
Plaque Modification Devices
Hemodynamic Flow Alteration Devices
Other Devices
Old/Normal Balloons
Drug-eluting Balloons
Drug-eluting Stents
Bare Metal Stents
Balloon-expandable Stents
Self-expandable Stents
Angiography Catheters
Guiding Catheters
IVUS/OCT Catheters
Abdominal Endovascular Aneurysm Stent Grafts
Thoracic Endovascular Aneurysm Stent Grafts
Retrievable Filters
Permanent Filters
Atherectomy Devices
Thrombectomy Devices
Embolic Protection Devices
Chronic Total Occlusion Devices
Peripheral Vascular Devices Market, by Geography
North America
Europe
Asia Pacific
Latin America
Middle East & Africa
U.S.
Canada
Germany
France
U.K.
Italy
Spain
Rest of Europe (RoE)
China
India
Japan
Rest of APAC (RoAPAC)
Download Free Sample Report Now @ https://www.meticulousresearch.com/download-sample-report/cp_id=5180
0 notes
Photo
Go with the Flow
Robert Smith, 74, spent six years in terrible pain. He could barely walk and had stopped doing many of the things he loved, like playing golf. After what he calls “years of hell,” he was diagnosed with peripheral arterial disease (PAD), a condition caused by a build-up of plaque that blocks blood flow in the arteries of the legs and feet, preventing oxygen-rich blood from circulating throughout the extremities. An artery in Smith’s right leg was completely blocked.
“I was misdiagnosed for several years,” said Smith. “I did a lot of research and didn’t want to go through an invasive procedure, so I was so relieved to hear about new approaches at UC San Diego Health that could treat me, improve my quality of life and get me back on the golf course.”
One day after treatment, Smith was able to walk a mile pain-free.
“It was certainly worth the trip from Seattle to San Diego,” Smith said.
UC San Diego Health is on the forefront of treating PAD with new technologies, including catheters with cameras the size of a grain of salt that allow cardiologists to see inside smaller arteries for the first time. We asked Mitul Patel, MD, interventional cardiologist at UC San Diego Health, about PAD and the latest treatment options for a disease that affects approximately 20 million people in the United States.
Question: Who is at risk for PAD?
Answer: PAD affects more than 200 million people globally. Risk factors for the development of PAD include smoking, high blood pressure, diabetes, high cholesterol, obesity and advanced age, with 12 to 20 percent of individuals older than age 60 being affected. People with PAD have a higher risk of coronary artery disease, heart attack and stroke. Left untreated, PAD can lead to gangrene and amputation. You can take control and prevent PAD by pursuing a heart-healthy lifestyle with regular exercise and a balanced diet and by managing the relevant risk factors mentioned.
Q: What are the symptoms of PAD and when should you see a doctor?
A: Robert was a typical patient with classic symptoms of PAD, which included cramping in the affected extremity that occurred with even minor exertion and improved to some degree with rest. Many people with PAD mistake the symptoms of PAD for something else, such as sciatica or “nerve pain”, or are misdiagnosed, like Robert was. Other common PAD symptoms include change in the color of the legs, coldness in the lower leg or foot, leg numbness or weakness and sore toes. Should these symptoms arise, you should inform your primary care physician who can refer you to a vascular specialist for further evaluation and treatment.
Q: What are the latest treatment options for PAD?
A: The initial evaluation is fairly simple and easy and usually starts with measuring blood pressures in the limbs and determining any differences in the blood pressures (called ankle-brachial index or ABI). An ultrasound of the arteries may also be performed. Depending on the results of these preliminary tests, further testing with computed tomography angiography, magnetic resonance angiography or invasive angiography may be done to determine the best treatment option.
A variety of treatment options are available for the management of intermittent blockages due to PAD. The initial therapies include management of PAD risk factors, such as high blood pressure, high cholesterol and diabetes. In most cases, lifestyle changes and medications are enough to slow the progression or even reverse symptoms of PAD. If the patient remains symptomatic after these steps have been taken, the next approach is revascularization, or restoring blood flow. Revascularization can be accomplished with open bypass surgery, but more recently, the majority of peripheral revascularization involves endovascular therapy — treating blockages with devices that may remove or modify plaque followed by balloon angioplasty if needed, and in some instances, with stent placement.
Perhaps the most advanced revascularization involves the technology we used to treat Robert, which involved the use of intravascular imaging with optical coherence tomography. This technology involves a catheter with a small fiber optic camera on the tip fed through a small incision in the groin and does not require full anesthesia. Once inside, the physician is able to see and extract the diseased areas or plaque without damaging the artery wall, which can cause recurrent narrowing of the blood vessels. Fluoroscopic technology is traditionally used during these procedures, but this newer technology reduces the use of fluoroscopy or X-ray radiation, which in high doses can have harmful effects.
At UC San Diego Health, we prefer to remove the plaque and then perform balloon angioplasty with a drug-coated balloon to prevent scar tissue build up in the artery going forward. To remove the plaque, we have been using intravascular imaging, which is integrated in the Avinger’s PantherisTM atherectomy catheter and allows us to cut out only the plaque, leaving healthy tissue behind. We have found that this advancement has led to better results with less use of radiation.
64 notes
·
View notes
Text
Peripheral Vascular Devices Market Size Worth $8,918.8 Million By 2020
The global peripheral vascular devices market is expected to reach USD 8,918.8 million by 2020, growing at an estimated CAGR of 7.2% from 2014 to 2020, according to a new study by Grand View Research, Inc. Peripheral vascular devices such as IVC filters, angiography catheters and plague modification devices are used for treating peripheral arterial or coronary arterial diseases caused due to the formation of atherosclerotic plaques in arteries. These devices are used to decrease the interference of patients with minimum disturbance during the surgical procedure.
Increasing global geriatric population base triggering incidence rates of target diseases, extensive presence of both private and public external funding programs, changing lifestyle and eating habits are expected to be key driving factors for this market over the next six years. In addition, presence of untapped growth opportunities in emerging markets such as India, Brazil and China and increasing health awareness are also expected to serve this market as future growth opportunities.
For More Details Please Visit @:
http://www.grandviewresearch.com/industry-analysis/peripheral-vascular-devices-market
Further key findings from the study suggest:
· Peripheral vascular stents dominated the peripheral vascular devices market in terms of share at over 30.8% in 2013; driven by increasing demand for drug eluting and bio-absorbable stents. Moreover, the ability of these devices to significantly reduce re-stenosis rates is expected to boost product demand.
· Embolic protection devices market is expected to grow at the fastest CAGR of 9.2% during the forecast period; owing to increasing demand for minimally invasive endovascular surgical method for removing atherosclerosis from large blood vessels.
· North America was the largest regional market in 2013, accounting for 40.3% of the global revenue. Presence of sophisticated healthcare infrastructure, high patient awareness levels, healthcare expenditure and high R&D pertaining to drug discovery and development are some of the factors accounting for its large share.
· Asia Pacific peripheral vascular devices market is expected to grow at the fastest CAGR of 10.0% from 2014 to 2020; primarily owing to the wide presence of unmet medical needs coupled with rapidly improving healthcare infrastructure in emerging markets of India and China.
· Key industry participants of this market include Abbott Laboratories, Angioscore Inc., Edward Lifesciences Corporation, Medtronic Inc., St. Jude Medical, Teleflex Medical, Volcano Corporation, Boston Scientific Corporation, Teleflex Medical, Cook Group Inc., Cordis Corporation, Covidien, W.L.Gore and Associates Ltd. and Angioscore Ltd.
Grand View Research has segmented the peripheral vascular devices market on the basis of product and region:
Peripheral Vascular Devices Product Outlook
· Peripheral Vascular Stents
· Peripheral Transluminal Angioplasty Balloon Catheters
· PTA Guidewires
· Atherectomy Devices
· Chronic Total Occlusion Devices
· Aortic Stents
· Synthetic Surgical Grafts
· Embolic Protection Devices
· Inferior Vena Cava Filters
Peripheral Vascular Devices Regional Outlook
· North America
· Europe
· Asia Pacific
· RoW
0 notes
Text
Peripheral Vascular Devices Market
Peripheral Vascular Devices Market is expected to reach USD 17.35 Billion by 2026 from USD 8.74 Billion in 2016 at a CAGR of 7.1% (Detailed analysis of the market CAGR is provided in the report).
Peripheral vascular disease (PVD) is a disorder of blood circulation that causes the blood vessels to become narrow or block. PVD is also known as arteriosclerosis obliterans, arterial insufficiency of the legs, claudication, intermittent claudication.
Peripheral Vascular Devices Market
The peripheral vascular devices market has been segmented into type and geography. The market based on type is classified into angioplasty balloons, angioplasty stents, catheters, endovascular aneurysm repair stent grafts, inferior vena cava filters, plaque modification devices, hemodynamic flow alteration devices, and other peripheral vascular devices. The angioplasty stents segment is expected to be one of the major contributors to the market growth. This can be attributed to the increasing number of peripheral vascular surgeries. The other peripheral vascular devices include guidewires, vascular closure devices, introducer sheaths, and balloon inflation devices. The guidewires segment is accounted for the largest market shares of the market. The rising use of guidewires in stenting procedures is one of the factors driving the growth of this segment.
Geographically, the market has been segmented into Asia-Pacific, North America, Europe, Middle-East & Africa and Latin America. North America became one of the major contributors for the peripheral vascular devices market followed by Europe. Increasing incidence of peripheral vascular diseases in aging population is one of the major factors driving the market growth for peripheral vascular devices.
The years that have been considered for the market analysis are:
• Base year – 2016
• Estimated year – 2017
• Forecast period – 2016 to 2026
Key Highlights:
• Peripheral vascular devices market analysis and forecast, in terms of value.
• Comprehensive study and analysis of market drivers, restraints and opportunities influencing the growth of the peripheral vascular devices market.
• Peripheral vascular devices market segmentation on the basic type and geography (country-wise) has been provided.
• Peripheral vascular devices market strategic analysis with respect to individual growth trends, future prospects along with a contribution of various sub-market stakeholders have been considered under the scope of the study.
• Peripheral vascular devices market analysis and forecast for five major regions namely North America, Europe, Asia Pacific, the Middle East & Africa (MEA) and Latin America along with country-wise segmentation.
• Profiles of key industry players, their strategic perspective, market positioning and analysis of core competencies are further profiled.
• Competitive developments, investments, strategic expansion and competitive landscape of the key players operating in the peripheral vascular devices market are also profiled.
Research Methodology:
The market is estimated by triangulation of data points obtained from various sources and feeding them into a simulation model created individually for each market. The data points are obtained from paid and unpaid sources along with paid primary interviews with key opinion leaders (KOLs) in the market. KOLs from both, demand and supply side were considered while conducting interviews to get an unbiased idea of the market. This exercise was done at country level to get a fair idea of the market in countries considered for this study. Later this country-specific data was accumulated to come up with regional numbers and then arrive at the global market value for Peripheral Vascular Devices Market.
The major players operating in the peripheral vascular devices market include:
• Medtronic (US)
• B. Braun (Germany)
• Terumo (Japan)
• Abbott Laboratories (US)
• Cordis (US)
• C.R. Bard (US)
• Boston Scientific (US)
• Biosensors (Singapore)
• BIOTRONIK (Germany).
Key Target Audience:
• Manufacturers and vendors of peripheral vascular devices
• Research associations related to non-communicable diseases
• Distributors of peripheral vascular devices
• Various research and consulting firms
• Contract research manufacturers of peripheral vascular devices
• Healthcare Research institutions
Scope of the Peripheral Vascular Devices Market Report:
The Research report segments the peripheral vascular devices market based on type and geography
Peripheral Vascular Devices Market, By Type:
• Angioplasty Balloons
• Old/Normal Balloons
• Cutting and Scoring Balloons
• Drug-eluting Balloons
• Angioplasty Stents
• Drug-eluting Stents
• Bare Metal Stents
• Catheters
• Angiography Catheters
• IVUS/OCT Catheters
• Guiding Catheters
• Endovascular Aneurysm Repair Stent Grafts
• Abdominal Aortic Aneurysms
• Thoracic aortic aneurysms
• Inferior Vena Cava Filters
• Retrievable Filters
• Permanent Filters
• Plaque Modification Devices
• Atherectomy Devices
• Thrombectomy Devices
• Hemodynamic Flow Alteration Devices
• Embolic Protection Devices
• Chronic Total Occlusion Devices
• Other Peripheral Vascular Devices
• Guidewires
• Vascular Closure Devices
• Introducer Sheaths
• Balloon Inflation Devices
Peripheral Vascular Devices Market: By Geography:
• North America
• Europe
• Asia Pacific
• Middle East & Africa
• Latin America
Geographic Analysis
• Breakdown of North America Peripheral Vascular Devices Market
• Breakdown of Europe Peripheral Vascular Devices Market
• Breakdown of Asia Pacific Peripheral Vascular Devices Market
• Breakdown of Middle East & Africa Peripheral Vascular Devices Market
• Breakdown of Latin America Peripheral Vascular Devices Market
This Report Is Submitted By @Maximize Market Research Company
Customization of the report:
Maximize Market Research provides free personalized of reports as per your demand. This report can be personalized to meet your requirements. Get in touch with us and our sales team will guarantee provide you to get a report that suits your necessities.
About Maximize Market Research:
Maximize Market Research provides B2B and B2C research on 20,000 high growth emerging opportunities & technologies as well as threats to the companies across the Healthcare, Pharmaceuticals, Electronics & Communications, Internet of Things, Food and Beverages, Aerospace and Defense and other manufacturing sectors.
Contact Us:
Name: Lumawant Godage
Organization: MAXIMIZE MARKET RESEARCH
Email: [email protected]
Contact:
+91 9607365656
0 notes
Text
Research and Markets: Global Atherectomy and Thrombectomy Devices Market 2014-2018
New Post has been published on https://vizrelease.com/press-release/1768970/
Research and Markets: Global Atherectomy and Thrombectomy Devices Market 2014-2018
There is an increasing demand for minimally invasive surgery among the rapidly increasing aging population in the world, and this is expected to propel the growth of the Global Atherectomy and Thrombectomy Devices market. Minimally invasive endovascular procedures are performed through minute incisions in the body. Such procedures can be used to treat plaque blockages in the arteries of the heart and other vessel walls of peripheral organs such as kidneys and brain.
The principal advantages of these procedures, over conventional surgical methods, are the short recovery time, less physical trauma, minimal scarring, low risk of infection, minimal bleeding, low cost, and shorter hospital stays. Therefore, the increasing demand for minimally invasive surgery is expected to increase the demand for atherectomy and thrombectomy devices during the forecast period.
According to the report, one of the key drivers in this market is the increasing prevalence of cardiovascular diseases such as AAAs and PADs. The increase in the aging population, patient lifestyle changes and unhealthy habits, and the presence of genetic influences and comorbidity among patients has resulted in a high incidence of acute PVD in the global population.
Further, the report states that one of the major challenges faced by vendors in the market is the lack of awareness about PVDs among patients. This is primarily due to the asymptomatic nature of vascular diseases, wherein patients do not realize and are unaware of the immediate symptoms.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
– Bayer AG
– Boston Scientific Corp.
– Covidien plc
– Cardiovascular Systems Inc.
– Spectranetics Corp.
– Argon Medical Devices Inc.
– Accellent Inc. AtheroMed Inc.
– C.R. Bard Inc.
– Cod Man Neuro
– (DePuy Orthopaedics Inc.)
– Cook Medical Inc. Edwards Lifesciences Corp.
– IDEV Technologies Inc.
– Lazarius Effect
– Medtronic Inc.
– NexGen Medical Systems Inc.
– Reverse Medical Corp.
– St. Jude Medical Inc.
– and Teleflex Medical Inc.
Research and Markets is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
0 notes
Link
Atherectomy is a minimally invasive endovascular surgical process which is used to remove the atherosclerosis from blood vessels within the body. This is a substitute of angioplasty which is used for the diagnosis of peripheral artery disease. The concept of atherectomy is based on obtaining significant lumen by clearing plaque and calcified lesions from the artery which helps in restoring the blood flow of arteries.
#Atherectomy Devices Market#Atherectomy Devices#Atherectomy Devices Market Trends#Atherectomy Devices Market Industry#Atherectomy Devices Market News
0 notes
Text
Atherectomy and Thromboctomy Devices Market Set to Garner Staggering Revenues by 2025
Atherectomy devices are used to eliminate atherosclerotic plate from infected arteries. Atherosclerotic plaques are located in either peripheral or coronary arterial vasculature and have different features dependent on the texture of the plaque. Atherectomy is an endovascular process for the treatment of CAD and PAD. PVD refers to blocked or damaged peripheral blood vessels that supply blood to the legs, arms, and organs other than heart and brain.
View Report –
https://www.transparencymarketresearch.com/atherectomy-thromboctomy-devices-market.html
Atherectomy devices are specifically designed to either shave, cut, or vaporize atherosclerotic plaques, and have different symptoms. Thrombectomy devices are used to removal of thrombi (clot) from the blood vessels during the treatment of deep vein thrombosis. Deep vein thrombosis is blood clot formed in deep veins in the body, mostly in legs. The risk of evolving these vascular disorders increases with age. Obesity, high blood pressure, smoking, and diabetes are the other risk factors for these disorders.
Increase in prevalence of cardiovascular disorders such as high blood pressure, congestive heart failure, coronary artery disease, arrhythmia, cardiac arrest, peripheral artery disease, stroke, and congenital heart diseases is expected to fuel the growth of the global atherectomy and thrombectomy devices market during the forecast period.
Request to View Brochure of Report –
https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=4584
The global atherectomy and thrombectomy devices market can be segmented based on product type and region. In terms of product type, the global atherectomy market can be classified into rotational, excisional, directional, excimer laser, Jetstream, and orbital atherectomy. The directional and orbital atherectomy segments account for the major share of the global atherectomy market due to reduced procedure time, quicker blood flow restoration, minimal invasive treatment, and application in complex patient cases. For example, Turbohawk and Silver Hawk methods are directional atherectomy equipment, different in size and efficiency, used to treat of large injuries.
Laser atherectomy is anticipated to gain popularity owing to higher success rate, minimum injury to the tissues, reduced trauma, and ability to treat complex lesions. Based on product type, the global thrombectomy devices market can be divided into rotational, rheolytic, ultrasound, and aspiration devices. Ultrasound thrombolytic procedures are projected to gain significant market share owing to accuracy, better coverage to the surgery sites, better permeation through wounds, no other usage of thrombolytic mediators, and reduced collateral damage.
Key players in the global atherectomy and thrombectomy devices market are Zoll Medical Corp., Boston Scientific Corp., Medtronic plc, Bayer AG, Cardiovascular Systems, Inc., Argon Medical Devices, Vascular Solutions, Inc., Uscom Ltd., Terumo Medical Corp., Abbott, Sorin Group USA Inc., Ventracor Ltd., Spectranetics Corp., Straub Medical AG, and Getinge AB.
0 notes
Last Seen Blogs
skater110599
Autumn's Place
inkling-society
Goddess Gangland
ice-nine
this is not for you.
bris1d
ஐ
norstappen
norstappen → rb19